Dopamine 200mg/5ml concentrate for solution for infusion ampoules

Riik: Suurbritannia

keel: inglise

Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Toimeaine:

Dopamine hydrochloride

Saadav alates:

Advanz Pharma

ATC kood:

C01CA04

INN (Rahvusvaheline Nimetus):

Dopamine hydrochloride

Annus:

40mg/1ml

Ravimvorm:

Solution for infusion

Manustamisviis:

Intravenous

Klass:

No Controlled Drug Status

Retsepti tüüp:

Valid as a prescribable product

Toote kokkuvõte:

BNF: 02070100; GTIN: 5021691164159

Infovoldik

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
If any of the side effects becomes serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor or
pharmacist.
The name of your medicine is Dopamine Hydrochloride 40mg/ml
Concentrate f
or Solution for Infusion. It will be referred to as “Dopamine
Concentrate” for ease of use hereafter.
In this leaflet:
1. What Dopamine Concentrate is and what it is used for
2. Before you are given Dopamine Concentrate
3. How Dopamine Concentrate is given
4. Possible side effects
5. How to store Dopamine Concentrate
6. Further information
1. WHAT DOPAMINE CONCENTRATE IS AND
WHAT IT IS USED FOR
Dopamine
Hydrochloride
40mg/ml
Concentrate
For
Solution
For
Infusion contains 200mg of Dopamine Hydrochloride which helps to
increase the strength of muscle contraction in the heart.
It is used to correct poor circulation to the tissues
• when there is a low output of blood from the heart and shock
associated with damage to the heart muscle due to obstruction of its
blood supply.
• also
after an injury, blood infection, heart failure and open heart
surgery.
2. BEFORE YOU ARE GIVEN
DOPAMINE CONCENTRATE
DOPAMINE CONCENTRATE SHOULD NOT BE USED IF:
• you
know
that
you
are
allergic
to
Dopamine
or
to
any
other
ingredients (see section 6 of this leaflet).
• you have been told by your doctor that you have a tumour of the
adrenal gland (phaeochromocytoma).
• you have abnormal heartbeats and uncoordinated contraction of the
heart muscles.
• you have an overactive thyroid gland
TAKE SPECIAL CARE
AND TELL YOUR DOCTOR IF:
• you have any heart related problems
• you have recently used monoamine oxidase inhibitors (known as
MAOIs which are used for the treatment of depression; see section
“Taking other medicines” for further information)
• you are sensitive to sulphite
• you have a weaker pulse in your wrists

Toote omadused

OBJECT 1
DOPAMINE HYDROCHLORIDE 40MG/ML CONCENTRATE
FOR SOLUTION FOR INFUSION
Summary of Product Characteristics Updated 19-Nov-2014 | Concordia
International - formerly AMCo
1. Name of the medicinal product
Dopamine Hydrochloride 40mg/ml Concentrate for Solution for Infusion
2. Qualitative and quantitative composition
Dopamine hydrochloride USP, 200mg in 5ml.
3. Pharmaceutical form
Clear, colourless or pale yellow sterile solution intended for
parenteral administration to human beings.
4. Clinical particulars
4.1 Therapeutic indications
For the correction of haemodynamic imbalances in low-perfusion
circulatory insufficiency associated
with myocardial infarction, trauma, septicaemia, cardiac failure and
open heart surgery.
4.2 Posology and method of administration
The solution must be diluted before administration. Alkaline solutions
such as 5% sodium bicarbonate
should NOT be added to dopamine hydrochloride because the drug will be
inactivated. The usual dilution
is 1,600 micrograms per ml and this may be achieved by transfer,
aseptically of 800mg of dopamine
hydrochloride to one of the following sterile I.V. solutions: -
Sodium Chloride Injection
5% Glucose Injection
5% Glucose and 0.9% Sodium Chloride Injection
5% Glucose and 0.45% Sodium Chloride Solution
5% Glucose in Ringer Lactate Solution
Sodium Lactate 1/6 Molar Injection
Lactated Ringer's Injection
A suitable metering device is required in the infusion system to
control the rate of flow, and this should
be adjusted to the optimum patient response and monitored constantly
in the light of the individual
patient's response.
Adults: Use as large a vein as possible for infusion. The initial rate
of infusion is 2 to 5 micrograms per
kilogram bodyweight per minute and this may be increased gradually by
increments of 5 to 10
micrograms/kg/minute until the optimum dose for the individual is
achieved. Up to 50
micrograms/kg/minute may be required, and even higher doses have been
used.
Children: The safety and efficacy of dopamine hydrochloride therapy in
children